• 6308 Citations
  • 33 h-Index
1991 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 6308 Citations
  • 33 h-Index
  • 118 Article
  • 6 Review article
  • 5 Letter
  • 1 Comment/debate
Filter
Article
2015

The potential role of HLA-DRB1∗11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy

Balassa, K., Andrikovics, H., Remenyi, P., Batai, A., Bors, A., Kiss, K. P., Szilvasi, A., Rajczy, K., Inotai, D., Gopcsa, L., Lengyel, L., Barta, A., Reti, M., Tordai, A. & Masszi, T., okt. 1 2015, In : Bone Marrow Transplantation. 50, 10, p. 1321-1325 5 p.

Research output: Article

12 Citations (Scopus)
2014

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up

Gambacorti-Passerini, C., Brümmendorf, T. H., Kim, D. W., Turkina, A. G., Masszi, T., Assouline, S., Durrant, S., Kantarjian, H. M., Khoury, H. J., Zaritskey, A., Shen, Z. X., Jin, J., Vellenga, E., Pasquini, R., Mathews, V., Cervantes, F., Besson, N., Turnbull, K., Leip, E., Kelly, V. & 1 others, Cortes, J. E., júl. 2014, In : American Journal of Hematology. 89, 7, p. 732-742 11 p.

Research output: Article

67 Citations (Scopus)

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations

Andrikovics, H., Krahling, T., Balassa, K., Halm, G., Bors, A., Koszarska, M., Batai, A., Dolgos, J., Csomor, J., Egyed, M., Sipos, A., Remenyi, P., Tordai, A. & Masszi, T., júl. 1 2014, In : Haematologica. 99, 7, p. 1184-1190 7 p.

Research output: Article

62 Citations (Scopus)

Komplex molekuláris genetikai vizsgálati algoritmus myeloproliferativ neoplasiák diagnosztikájában

Krhling, T., Balassa, K., Meggyesi, N., Bors, A., Csomor, J., Bátai, Á., Halm, G., Egyed, M., Fekete, S., Reményi, P., Masszi, T., Tordai, A. & Andrikovics, H., dec. 1 2014, In : Orvosi hetilap. 155, 52, p. 2074-2081 8 p.

Research output: Article

4 Citations (Scopus)

Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort

Koszarska, M., Meggyesi, N., Bors, A., Batai, A., Csacsovszki, O., Lehoczky, E., Adam, E., Kozma, A., Lovas, N., Sipos, A., Krahling, T., Dolgos, J., Remenyi, P., Fekete, S., Masszi, T., Tordai, A. & Andrikovics, H., júl. 2014, In : Leukemia and Lymphoma. 55, 7, p. 1510-1517 8 p.

Research output: Article

4 Citations (Scopus)

Mennyit vár ma Magyarországon egy myelomás beteg a diagnózisig?

Varga, G., Mikala, G., Andrikovics, H. & Masszi, T., szept. 1 2014, In : Orvosi hetilap. 155, 39, p. 1538-1543 6 p.

Research output: Article

2 Citations (Scopus)

Peripheral Blood Stem Cell Mobilization and Engraftment after Autologous Stem Cell Transplantation with Biosimilar rhG-CSF

Reményi, P., Gopcsa, L., Marton, I., Réti, M., Mikala, G., Pető, M., Barta, A., Bátai, Á., Farkas, Z., Borbényi, Z., Csukly, Z., Bodó, I., Fábián, J., Király, Á., Lengyel, L., Piukovics, K., Torbágyi, É. & Masszi, T., ápr. 1 2014, In : Advances in Therapy. 31, 4, p. 451-460 10 p.

Research output: Article

19 Citations (Scopus)
33 Citations (Scopus)
2013

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: Comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus cy as conditioning regimen-A report from the acute leukemia working party of theeuropean group for blood and marrow transplantation

Nagler, A., Rocha, V., Labopin, M., Unal, A., Ben Othman, T., Campos, A., Volin, L., Poire, X., Aljurf, M., Masszi, T., Socie, G., Sengelov, H., Michallet, M., Passweg, J., Veelken, H., Yakoub-Agha, I., Shimoni, A. & Mohty, M., okt. 1 2013, In : Journal of Clinical Oncology. 31, 28, p. 3549-3556 8 p.

Research output: Article

85 Citations (Scopus)

Quality of life and its socio-demographic and psychological determinants after bone marrow transplantation

Janicsák, H., Masszi, T., Reményi, P., Ungvari, G. S. & Gazdag, G., aug. 1 2013, In : European journal of haematology. 91, 2, p. 135-140 6 p.

Research output: Article

10 Citations (Scopus)

Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma

Ludwig, H., Viterbo, L., Greil, R., Masszi, T., Spicka, I., Shpilberg, O., Hajek, R., Dmoszynska, A., Paiva, B., Vidriales, M. B., Esteves, G., Stoppa, A. M., Robinson, D., Ricci, D., Cakana, A., Enny, C., Feng, H., Van De Velde, H. & Harousseau, J. L., jan. 10 2013, In : Journal of Clinical Oncology. 31, 2, p. 247-255 9 p.

Research output: Article

60 Citations (Scopus)
5 Citations (Scopus)

Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia

Koszarska, M., Bors, A., Feczko, A., Meggyesi, N., Batai, A., Csomor, J., Adam, E., Kozma, A., Orban, T. I., Lovas, N., Sipos, A., Karaszi, E., Dolgos, J., Fekete, S., Reichardt, J., Lehoczky, E., Masszi, T., Tordai, A. & Andrikovics, H., máj. 1 2013, In : Leukemia and Lymphoma. 54, 5, p. 1028-1035 8 p.

Research output: Article

19 Citations (Scopus)
2012
5 Citations (Scopus)

Characterization and function of histamine receptors in human bone marrow stromal cells

Nemeth, K., Wilson, T., Rada, B., Parmelee, A., Mayer, B., Buzas, E., Falus, A., Key, S., Masszi, T., Karpati, S. & Mezey, E., febr. 1 2012, In : Stem Cells. 30, 2, p. 222-231 10 p.

Research output: Article

19 Citations (Scopus)
6 Citations (Scopus)

Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis

Nicolini, F. E., Masszi, T., Shen, Z., Gallagher, N. J., Jootar, S., Powell, B. L., Dorlhiac-Llacer, P. E., Zheng, M., Szczudlo, T. & Turkina, A., máj. 1 2012, In : Leukemia and Lymphoma. 53, 5, p. 907-914 8 p.

Research output: Article

16 Citations (Scopus)

Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia

Trask, P. C., Cella, D., Besson, N., Kelly, V., Masszi, T. & Kim, D. W., ápr. 1 2012, In : Leukemia Research. 36, 4, p. 438-442 5 p.

Research output: Article

29 Citations (Scopus)
65 Citations (Scopus)

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: Safety and efficacy data in a series of 21 patients from Europe and the USA

Douglas, K. W., Parker, A. N., Hayden, P. J., Rahemtulla, A., D'Addio, A., Lemoli, R. M., Rao, K., Maris, M., Pagliuca, A., Uberti, J., Scheid, C., Noppeney, R., Cook, G., Bokhari, S. W., Worel, N., Mikala, G., Masszi, T., Taylor, R. & Treisman, J., jan. 1 2012, In : Bone Marrow Transplantation. 47, 1, p. 18-23 6 p.

Research output: Article

15 Citations (Scopus)

Superiority of the triple combination of bortezomib-thalidomide- dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: The MMVAR/IFM 2005-04 randomized phase III trial from the chronic leukemia working party of the European Group for blood and marrow transplantation

Garderet, L., Iacobelli, S., Moreau, P., Dib, M., Lafon, I., Niederwieser, D., Masszi, T., Fontan, J., Michallet, M., Gratwohl, A., Milone, G., Doyen, C., Pegourie, B., Hajek, R., Casassus, P., Kolb, B., Chaleteix, C., Hertenstein, B., Onida, F., Ludwig, H. & 10 others, Ketterer, N., Koenecke, C., Van Os, M., Mohty, M., Cakana, A., Gorin, N. C., De Witte, T., Harousseau, J. L., Morris, C. & Gahrton, G., júl. 10 2012, In : Journal of Clinical Oncology. 30, 20, p. 2475-2482 8 p.

Research output: Article

170 Citations (Scopus)
2011

Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients

Meggyesi, N., Kozma, A., Halm, G., Nahajevszky, S., Bátai, Á., Fekete, S., Barta, A., Ujj, G., Lueff, S., Sipos, A., Ádám, E., Bors, A., Reményi, P., Masszi, T., Tordai, A. & Andrikovics, H., dec. 1 2011, In : Acta Haematologica. 127, 1, p. 34-42 9 p.

Research output: Article

16 Citations (Scopus)

Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population

Mohl, A., Boda, Z., Jager, R., Losonczy, H., Marosi, A., Masszi, T., Nagy, E., Nemes, L., Obser, T., Oyen, F., Radványi, G., Schlammadinger, Á., Szélessy, Z. S., Várkonyi, A., Vezendy, K., Vilimi, B., Schneppenheim, R. & Bodó, I., máj. 1 2011, In : Journal of Thrombosis and Haemostasis. 9, 5, p. 945-952 8 p.

Research output: Article

10 Citations (Scopus)

Gram-negatív bacteriaemia neutropeniás hematológiai betegekben. Tapasztalatok fluorokinolonprofilaxis alkalmazása kapcsán

Sinkó, J., Cser, V., Konkoly Thege, M. & Masszi, T., júl. 1 2011, In : Orvosi hetilap. 152, 27, p. 1063-1067 5 p.

Research output: Article

3 Citations (Scopus)

Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells

Basak, G. W., Jaksic, O., Koristek, Z., Mikala, G., Basic-Kinda, S., Mayer, J., Masszi, T., Giebel, S., Labar, B. & Wiktor-Jedrzejczak, W., jún. 1 2011, In : European journal of haematology. 86, 6, p. 488-495 8 p.

Research output: Article

31 Citations (Scopus)

Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilization

Basak, G. W., Jaksic, O., Koristek, Z., Mikala, G., Mayer, J., Masszi, T., Labar, B. & Wiktor-Jedrzejczak, W., júl. 1 2011, In : American Journal of Hematology. 86, 7, p. 550-553 4 p.

Research output: Article

20 Citations (Scopus)

Lymphoid aggregates may contribute to the migration and epithelial commitment of Bone marrow-derived cells in colonic mucosa

Valcz, G., Krenács, T., Sipos, F., Patai, Á. V., Wichmann, B., Leiszter, K., Tóth, K., Balogh, Z., Csizmadia, A., Hagymási, K., Masszi, T., Molnár, B. & Tulassay, Z., szept. 1 2011, In : Journal of Clinical Pathology. 64, 9, p. 771-775 5 p.

Research output: Article

8 Citations (Scopus)

Plerixafor to rescue failing chemotherapy-based stem cell mobilization: It's not too late

Basak, G. W., Mikala, G., Koristek, Z., Jaksic, O., Basic-Kinda, S., Cegledi, A., Reti, M., Masszi, T., Mayer, J., Giebel, S., Hbel, K., Labar, B. & Wiktor-Jedrzejczak, W., szept. 1 2011, In : Leukemia and Lymphoma. 52, 9, p. 1711-1719 9 p.

Research output: Article

21 Citations (Scopus)

Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma

Györke, T., Kollár, A., Bottlik, G., Szepesi, Á., Bodó, I., Masszi, T., Bérczi, V. & Garai, I., ápr. 1 2011, In : International Journal of Hematology. 93, 4, p. 545-550 6 p.

Research output: Article

3 Citations (Scopus)
2010

Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza

Gézsi, A., Budde, U., Deák, I., Nagy, E., Mohl, A., Schlammadinger, Á., Boda, Z., Masszi, T., Sadler, J. E. & Bodó, I., jún. 1 2010, In : Journal of Thrombosis and Haemostasis. 8, 6, p. 1273-1280 8 p.

Research output: Article

18 Citations (Scopus)

Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin

Skribek, H., Otvos, R., Flaberg, E., Nagy, N., Markasz, L., Eksborg, S., Masszi, T., Kozma, A., Adam, E., Miseta, A., Klein, E. & Szekely, L., dec. 1 2010, In : Experimental Hematology. 38, 12, p. 1219-1230 12 p.

Research output: Article

10 Citations (Scopus)

Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study: Efficacy and tolerability of 140 milligrams once daily and 70 milligrams twice daily

Saglio, G., Hochhaus, A., Goh, Y. T., Masszi, T., Pasquini, R., Maloisel, F., Erben, P., Cortes, J., Paquette, R., Bradley-Garelik, M. B., Zhu, C. & Dombret, H., aug. 15 2010, In : Cancer. 116, 16, p. 3852-3861 10 p.

Research output: Article

88 Citations (Scopus)

Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the european group for blood and marrow transplantation

Cesaro, S., Marsh, J., Tridello, G., Rovò, A., Maury, S., Montante, B., Masszi, T., Van Lint, M. T., Afanasyev, B., Iriondo Atienza, A., Bierings, M., Carbone, C., Doubek, M., Lanino, E., Sarhan, M., Risitano, A., Steinerova, K., Wahlin, A., Pegoraro, A. & Passweg, J., júl. 2010, In : Acta Haematologica. 124, 1, p. 19-22 4 p.

Research output: Article

7 Citations (Scopus)

Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration

Marschalkó, M., Eros, N., Holló, P., Hársing, J., Bottlik, G., Bátai, Á., Csukly, Z., Masszi, T., Szentirmai, Z., Fodor, J., Kárpáti, S., Matolcsy, A. & Csomor, J., okt. 1 2010, In : American Journal of Dermatopathology. 32, 7, p. 708-712 5 p.

Research output: Article

6 Citations (Scopus)
2009

A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older

Harousseau, J. L., Martinelli, G., Jedrzejczak, W. W., Brandwein, J. M., Bordessoule, D., Masszi, T., Ossenkoppele, G. J., Alexeeva, J. A., Beutel, G., Maertens, J., Vidriales, M. B., Dombret, H., Thomas, X., Burnett, A. K., Robak, T., Khuageva, N. K., Golenkov, A. K., Tothova, E., Mollgard, L., Park, Y. C. & 3 others, Bessems, A., De Porre, P. & Howes, A. J., 2009, In : Blood. 114, 6, p. 1166-1173 8 p.

Research output: Article

100 Citations (Scopus)

Familial multiple myeloma. Two more families

Várkonyi, J., Farkas, P., Tamáska, J., Masszi, T., Gopcsa, L., Padányi, Á. & Rajczy, K., dec. 1 2009, In : Central European Journal of Medicine. 4, 4, p. 501-505 5 p.

Research output: Article

HFE C282Y mutation as a genetic modifier influencing disease susceptibility for chronic myeloproliferative disease

Andrikovics, H., Meggyesi, N., Szilvasi, A., Tamaska, J., Halm, G., Lueff, S., Nahajevszky, S., Egyed, M., Varkonyi, J., Mikala, G., Sipos, A., Kalasz, L., Masszi, T. & Tordai, A., márc. 2009, In : Cancer Epidemiology Biomarkers and Prevention. 18, 3, p. 929-934 6 p.

Research output: Article

7 Citations (Scopus)

Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years

Giebel, S., Labopin, M., Holowiecki, J., Labar, B., Komarnicki, M., Koza, V., Masszi, T., Mistrik, M., Lange, A., Hellmann, A., Vitek, A., Pretnar, J., Mayer, J., Rzepecki, P., Indrak, K., Wiktor-Jedrzejczak, W., Wojnar, J., Krawczyk-Kulis, M., Kyrcz-Krzemien, S. & Rocha, V., 2009, In : Annals of Hematology. 88, 10, p. 1005-1013 9 p.

Research output: Article

26 Citations (Scopus)

Serum β2-microglobulin measured by immunonephelometry: Expression patterns and reference intervals in healthy adults

Mátrai, Z., Németh, J., Miklós, K., Szabó, Z. & Masszi, T., máj. 1 2009, In : Clinical Chemistry and Laboratory Medicine. 47, 5, p. 585-589 5 p.

Research output: Article

12 Citations (Scopus)

VMP (Bortezomib, melphalan, and prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: Cohort analysis of the phase III VISTA study

Dimopoulos, M. A., Richardson, P. G., Schlag, R., Khuageva, N. K., Shpilberg, O., Kastritis, E., Kropff, M., Petrucci, M. T., Delforge, M., Alexeeva, J., Schots, R., Masszi, T., Mateos, M. V., Deraedt, W., Liu, K., Cakana, A., Van De Velde, H. & San Miguel, J. F., dec. 20 2009, In : Journal of Clinical Oncology. 27, 36, p. 6086-6093 8 p.

Research output: Article

131 Citations (Scopus)
2008

An Alu-mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary

Mohl, A., Marschalek, R., Masszi, T., Nagy, E., Obser, T., Oyen, F., Sallai, K., Bodó, I. & Schneppenheim, R., szept. 30 2008, In : Journal of Thrombosis and Haemostasis. 6, 10, p. 1729-1735 7 p.

Research output: Article

18 Citations (Scopus)
24 Citations (Scopus)

Drugs, gene transfer, signaling factors: A bench to bedside approach to myocardial stem cell therapy

Vertesaljai, M., Piroth, Z., Fontos, G., Andreka, G., Font, G., Szantho, G., Lueff, S., Reti, M., Masszi, T., Ablonczy, L., Juhasz, E. D., Simor, T., Turner, M. S. & Andreka, P., jún. 1 2008, In : Heart Failure Reviews. 13, 2, p. 227-244 18 p.

Research output: Article

10 Citations (Scopus)

Haematopoietic stem cell transplantation in children in eastern European countries 1985-2004: Development, recent activity and role of the EBMT/ ESH Outreach Programme

Wachowiak, J., Labopin, M., Miano, M., Chybicka, A., Stary, J., Sterba, J., Masszi, T., Labar, B., Maschan, A., Kowalczyk, J. R., Lange, A., Holowiecki, J., Kalman, N., Afanassiev, B. V. & Dini, G., jún. 1 2008, In : Bone Marrow Transplantation. 41, SUPPL. 2, p. S112-S117

Research output: Article

14 Citations (Scopus)

Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: An autopsy-driven survey

Sinkó, J., Csomor, J., Nikolova, R., Lueff, S., Kriván, G., Reményi, P., Bátai, Á. & Masszi, T., ápr. 1 2008, In : Transplant Infectious Disease. 10, 2, p. 106-109 4 p.

Research output: Article

44 Citations (Scopus)

Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation

Tichelli, A., Passweg, J., Wójcik, D., Rovó, A., Harousseau, J. L., Masszi, T., Zander, A., Békássy, A., Crawley, C., Arat, M., Sica, S., Lutz, P. & Socié, G., aug. 2008, In : Haematologica. 93, 8, p. 1203-1210 8 p.

Research output: Article

109 Citations (Scopus)
2007

A 2-es típusú Janus tirozin kináz Val617Phe aktiváló pontmutáció szerepe és kimutatásának jelentosége myeloproliferatív szindrómában

Andrikovics, H., Szilvási, A., Meggyesi, N., Király, V., Halm, G., Lueff, S., Nahajevszky, S., Mikala, G., Sipos, A., Lovas, N., Csukly, Z., Mátrai, Z., Tamáska, J., Tordai, A. & Masszi, T., febr. 4 2007, In : Orvosi hetilap. 148, 5, p. 203-210 8 p.

Research output: Article

9 Citations (Scopus)

A myeloma multiplex bortezomibalapú kezelése: Hazai tapasztalatok az elso 60 beteg adatainak tükrében

Gábor, M., Árpád, B., Andrea, C., Zoltán, C., János, D., Gabriella, H., Judit, J., Balázs, K., Nóra, L., Sándor, L., Mónika, P., Péter, R., Andrea, S., Zsuzsanna, T. & Tamás, M., jan. 1 2007, In : Lege Artis Medicinae. 17, 1, p. 26-34 9 p.

Research output: Article

Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: A randomized phase 2 trial

Kantarjian, H., Pasquini, R., Hamerschlak, N., Rousselot, P., Holowiecki, J., Jootar, S., Robak, T., Khoroshko, N., Masszi, T., Skotnicki, A., Hellmann, A., Zaritsky, A., Golenkov, A., Radich, J., Hughes, T., Countouriotis, A. & Shah, N., jún. 15 2007, In : Blood. 109, 12, p. 5143-5150 8 p.

Research output: Article

323 Citations (Scopus)